About: News/Events
RedPath Integrated Pathology, Inc. Concludes Series A Round with $6.5 Million in Venture Capital
Press Release: Pittsburgh, PA - December 18, 2006
RedPath Integrated Pathology, Inc. reports that Seneca Health Partners, Inflexion Partners, and HMA Capital Partners have invested in the Pittsburgh-based cancer diagnostics company as part of RedPath's final closing of their Series A round of institutional investment.

Case Study of the Week